SCOPE-Chinese Women Study
Cancer, Breast · Obesity, Abdominal
What this study involves
The registry does not currently label this study as recruiting. Ask about its status before planning a screening visit.
- Study type
- Interventional
- Phase
- Not applicable
- Age range
- 18 years - Not specified
- Sex eligible
- Female
- Healthy volunteers
- Accepted
- Participants
- 102 Actual
These are starting points, not an eligibility decision. The research team must review the full requirements.
About the research
This project examines the feasibility of a smartphone-based intervention to reduce obesity and breast cancer risk among Chinese women in China. The proposed intervention is to use the mobile application and an activity tracker device to promote a healthier lifestyle and physical activity. The intervention will be tailored to the participants' behaviors, personal needs, and preferences. The aim is to reduce abdominal obesity and improve healthy lifestyle behaviors in premenopausal women with children in order to reduce the growing cancer burden in China.
Read the full description
Cancer presents a major disease burden across the globe. The incidence and mortality of gynecologic cancers have increased significantly in China over the last two decades with breast and endometrial cancer as leading causes of death in women in China. Obesity, especially abdominal obesity, and unhealthy lifestyles are major risk factors for breast and endometrial cancer. A high risk group for obesity is mothers with dependent children as they have high levels of stress and family responsibilities that prevent regular engagement in a healthy lifestyle and early screening activities. Because reducing postmenopausal abdominal obesity is very difficult and because of the significant increased risk for gynecologic cancers in obese postmenopausal women, interventions that aim to reduce abdominal obesity and improve healthy lifestyle behaviors in premenopausal women with children are critical to reducing the growing cancer burden in China. A smartphone-based intervention provides a promising platform for obesity and cancer prevention. In this proposed study, the research team will modify the Healthy Mothers Healthy Children: Technology-Based Intervention to Prevent Obesity, which was developed by the principal investigator. The proposed intervention (titled "The Smartphone-Based Cancer and Obesity Prevention Education Program for Chinese Women: SCOPE-Chinese Women") is a smartphone-based, data-driven, and individually tailored intervention. It includes 12 weekly educational modules and six bi-weekly tailored messages delivered via WeChat, a popular communication app in China. The intervention will also be tailored to the participants' behaviors, personal needs, and preferences. The overall goal of this proposed study is to assess the feasibility and estimate the preliminary efficacy of the SCOPE-Chinese Women intervention using a randomized control study design (RCT). The following aims will be addressed.
Aim 1: To assess the feasibility of the smartphone-based lifestyle intervention (i.e., SCOPE-Chinese Women).
Aim 2: To estimate the preliminary efficacy of the SCOPE-Chinese Women intervention on the primary outcome (waist circumference) and secondary outcomes (body mass index, self-efficacy, food intake, physical activity, and metabolic risk) between the intervention and control groups at baseline, 3 months, and 6 months.
Aim 3: To understand participants' acceptance, barriers to adherence, and recommendations for intervention.
Who may be able to participate?
The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.
Inclusion Criteria:
Participants must:
- Be female
- Be at least 18 years old
- Have a waist circumference great than 80 cm
- Own a smartphone
- Be able to read Chinese and speak Mandarin
- Be premenopausal
- Have a child between the age of 1 and 18 years old
Exclusion Criteria:
Women are excluded from the study if they:
- Are pregnant
- Gave birth less than 12 months prior to enrollment date
- Have an acute or life-threatening disease (e.g., renal failure).
Treatment, groups and participation
The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.
- Assignment
- Random assignment
- Masking
- Double masked
Control
Participants in the control group will receive a Fitbit Alta-Heart Rate (HR) and 12 weekly non-tailored educational modules via WeChat on general health topics that are important to 20-45 year-old women in China. Topics include intimate partner violence, anxiety, depression, sexually transmitted infections, HIV, unintended pregnancy, hepatitis B, and general cancer prevention.
SCOPE-Chinese Women Intervention
SCOPE-Chinese Women intervention content and methods: SCOPE-Chinese Women is a smartphone- based intervention.
Component 1. All study participants will receive a Fitbit Alta-HR tracking device to wear daily. Each participant will receive in-person, training on how to access the app and their tracking data. If a participant has not used the fitness device and app for more than one week, a WeChat reminder message will be sent to the participant.
Component 2. Participants will receive 12 weekly culturally appropriate and evidence-based SCOPE-Chinese Women educational modules along with tailored tips and messages via WeChat. Each module will include three educational sessions that last less than 45 minutes total.
Component 3. Six bi-weekly messages will be sent to participants via WeChat to encourage positive behavioral changes. Each participant's message content will be based on the participant's tracker information, personal goals, and preferences.
Other: SCOPE-Chinese Women
SCOPE-Chinese Women OTHER
SCOPE-Chinese Women is a smart-phone based intervention that includes a Fitbit tracking device to monitor daily activity, 12-weeks of educational modules delivered by WeChat, and Bi-weekly messages that encourage positive behavioral change. The data will be examined by the research team to assess efficacy of the intervention.
What researchers are measuring
Outcome measures describe what is being studied. They are not proof that a treatment works.
Primary measures
Mean Change in Waist Circumference Over Time
Time frame: Baseline, 3 months, and 6 months
The National Institutes of Health (NIH) waist circumference measurement protocol will be used to measure change in waist circumference for each participant over time.
Secondary measures
Mean Change in Body Mass Index (BMI) Over Time
Time frame: Baseline, 3 months, and 6 months
Weight and height will be used to compute the BMI with the formula=weight (kilograms(kg)) / height in (meters squared (m2). Changes in BMI will be collected for each participant over time.
Mean Change in Scores on the Self-Rated Abilities for Health Practices Scale Over Time
Time frame: Baseline, 3 months, and 6 months
The Self Rated Abilities for Health Practices Scale (SRAHP) is a 28-item survey, with each item scored on a 5-point scale, with item scores ranging from 0=Not at all to 4=Completely. The survey is designed to measure self-perceived ability to implement health-promoting behaviors across four subscales: Exercise, Nutrition, Responsible Health Practice, and Psychological Well Being, and overall. The total score ranges from 0 - 112, with higher scores indicating greater abilities for health practices. Changes in scores will be collected for each participant over time.
Mean Changes in China Food Frequency Questionnaire (FFQ) over time.
Time frame: Baseline, 3 months, and 6 months
Food intake using the China food frequency questionnaire (FFQ), which includes a list of 118 food items will be used to measure aggregate changes in food intake over time.
Mean Changes in Overall Physical Activity
Time frame: Baseline, 3 months, and 6 months
Change in overall Physical activity over time will be measured using the Fitbit Alta-HR device for 10 hours while participants are awake.
Mean Change in Blood Pressure Over Time
Time frame: Baseline, 3 months, and 6 months
Changes in blood pressure will be measured using the YuWell YE690A monitor for each participant over time.
Mean Change in Hemoglobin A1C (HbA1C) Over Time
Time frame: Baseline and 6 months
A blood sample will be collected to measure change in HbA1C over time for each participant, using an established cut off value at 6.4%.
Mean Change in Serum Lipid Levels Over Time
Time frame: Baseline and 6 months
A blood sample will be collected to measure change in total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides (all measured in milligrams per deciliter (mg/dL)) over time for each participant
Mean Change in Cortisol over time
Time frame: Baseline and 6 months
A blood sample will be collected to measure change in total cortisol levels over time for each participant.
Relative telomere length (RTL)
Time frame: baseline and 6 months follow-up.
A blood sample will be collected to measure relative telomere length (RTL), assessed using the real-time quantitative polymerase chain reaction (qPCR) technique, adhering to the protocol specified by Cawthon.
Other measures
Percentage of Eligible participants Who Agree To Be Screened
Time frame: At Baseline
The number of overall eligible participants and the number of eligible participants who agree to be screened will be used to compute the percentage used for enrollment.
Number of Uses of The Tracking App Over Time
Time frame: Baseline to 6 months
The number of uses of the tracking app and frequency of accessing the 12 modules, to measure change in usability over time
Percentage of Participants who completed assessments
Time frame: Up to 6 months
The percentage of completed assessments by participants at each visit will be used to measure adherence over time
Review the complete result tables and limitations in the official record.
Open official results ↗Research locations (2)
The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.
2 locations
University of California, San FranciscoSan Francisco, California, United StatesStatus unknown
Central South UniversityYuelucun, Changsha, Hunan, ChinaStatus unknown
Study team and timeline
- Lead sponsor
- University of California, San Francisco
- Study start
- Jul 20, 2020 Actual
- Primary completion
- Dec 30, 2022 Actual
- Study completion
- Dec 30, 2022 Actual
- First posted
- Mar 30, 2020 Actual
- Last updated
- Nov 10, 2026 Actual
Official study contacts
No central contact is listed. Check the locations and the official record.
Official study title
The Smartphone-Based Cancer and Obesity Prevention Education Program for Chinese Women (SCOPE-Chinese Women)
Ask Wellness Clinical Research
Your message goes to WCR, including when this study is run by another organization. WCR may offer general guidance but may not operate this trial, have access to its team or be able to enroll you.
Source: ClinicalTrials.gov API v2. Information is submitted by sponsors and investigators. NLM does not approve the safety or science of all listed studies. Registry disclaimer.
Retrieved: Nov 11, 2026 · Last registry update: Nov 10, 2026
